Man Group’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Man Group’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-212,209	Closed	-$3.9M	–	2085
2020 Q4	$3.9M	Sell	212,209 -35,629	-14%	-$649K	0.02%	938
2020 Q3	$4.54M	Buy	247,838 +140,158	+130%	+$2.36M	0.02%	864
2020 Q2	$1.61M	Sell	107,680 -32,500	-23%	-$464K	0.01%	1133
2020 Q1	$2.22M	Buy	+140,180	New	+$2.27M	0.01%	843

Man Group's CBMG Position: Q1 2021 in Review

Man Group sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 212,209 shares — an estimated $3.9M sold.

Man Group first reported a position in CBMG in Q1 2020 and held it in 4 quarters. The position peaked at $4.54M in Q3 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

Man Group reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
Man Group sold 212,209 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $3.9M.
Man Group first reported a position in Cellular Biomedicine Group, Inc. in Q1 2020 and held it in 4 quarters.
Man Group's Cellular Biomedicine Group, Inc. position peaked at $4.54M in Q3 2020.
0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Man Group's 13F filing for Q1 2021, filed 17 May 2021.